US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 41.490
  • +1.950+4.93%
Close Dec 20 16:00 ET
  • 41.490
  • 0.0000.00%
Post 18:05 ET
2.47BMarket Cap15.14P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.70%-27.86M
1,123.79%268.62M
20.14%-27.43M
35.05%-70.24M
153.61%16.96M
-5.60%-26.61M
-92.43%-26.24M
8.81%-34.35M
-0.25%-108.14M
-17.43%-31.64M
Net income from continuing operations
2.62%-33.21M
20.40%-30.62M
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
Depreciation and amortization
-21.77%647K
8.65%892K
-1.44%820K
-1.69%3.31M
-0.95%832K
-3.05%827K
-2.61%821K
-0.12%832K
21.41%3.37M
2.56%840K
Other non cash items
----
----
----
--194K
--0
--0
--0
--194K
----
----
Change In working capital
-389.32%-2.63M
7,144.00%291.06M
-2,950.34%-243.33M
-151.24%-19.51M
-471.73%-16.46M
232.94%908K
-79.56%4.02M
66.57%-7.98M
-134.34%-7.77M
-179.62%-2.88M
-Change in receivables
10.26%43K
2,499,900.00%300M
-707,321.95%-290.04M
-335.50%-9.99M
-12,295.12%-10M
-98.52%39K
-99.95%12K
99.83%-41K
563.61%4.24M
-45.70%82K
-Change in prepaid assets
-84.90%-1.16M
-241.15%-2.01M
-216.26%-915K
-53.30%1.75M
-94.88%171K
-194.16%-629K
192.83%1.42M
-38.47%787K
216.33%3.75M
661.51%3.34M
-Change in payables and accrued expense
52.17%3.33M
-168.55%-2.24M
140.76%3.28M
25.82%-8.53M
-5.47%-5.94M
166.05%2.19M
231.21%3.26M
-11,398.57%-8.05M
-172.45%-11.5M
-204.65%-5.63M
-Change in other current liabilities
76.05%-166K
23.09%-523K
-3.26%-696K
-3.08%-2.74M
-3.11%-696K
-3.28%-693K
-2.87%-680K
-3.06%-674K
-22.63%-2.66M
0.30%-675K
-Change in other working capital
---4.68M
---4.17M
--45.05M
----
----
----
----
----
87.57%-1.6M
--0
Cash from discontinued investing activities
Operating cash flow
-4.70%-27.86M
1,123.79%268.62M
20.14%-27.43M
35.05%-70.24M
153.61%16.96M
-5.60%-26.61M
-92.43%-26.24M
8.81%-34.35M
-0.25%-108.14M
-17.43%-31.64M
Investing cash flow
Cash flow from continuing investing activities
-1,439.27%-208.71M
-442.05%-88.12M
-38.21%6.07M
-142.92%-39.26M
-1,657.48%-61.29M
-123.67%-13.56M
-25.83%25.76M
319.53%9.83M
676.72%91.47M
-85.88%3.94M
Net PPE purchase and sale
-91.83%-775K
84.09%-28K
-2,320.00%-242K
23.40%-609K
72.86%-19K
-149.38%-404K
39.31%-176K
96.34%-10K
27.79%-795K
64.29%-70K
Net investment purchase and sale
-1,480.65%-207.94M
-439.62%-88.09M
-35.82%6.31M
-141.89%-38.65M
-1,629.79%-61.27M
-122.90%-13.16M
-25.94%25.94M
334.02%9.84M
725.13%92.26M
-85.73%4.01M
Cash from discontinued investing activities
Investing cash flow
-1,439.27%-208.71M
-442.05%-88.12M
-38.21%6.07M
-142.92%-39.26M
-1,657.48%-61.29M
-123.67%-13.56M
-25.83%25.76M
319.53%9.83M
676.72%91.47M
-85.88%3.94M
Financing cash flow
Cash flow from continuing financing activities
-65.88%12.05M
-97.62%2.57M
-72.80%7.2M
804.96%170.48M
-4.70%527K
5,093.38%35.32M
15,807.65%108.17M
56.35%26.46M
-85.50%18.84M
-74.55%553K
Net common stock issuance
--0
--0
--0
807.72%132.1M
--8K
---78K
--107.87M
66.99%24.3M
-88.25%14.55M
--0
Proceeds from stock option exercised by employees
-65.95%12.05M
164.34%2.57M
244.94%7.8M
780.08%39.15M
-6.15%519K
5,089.59%35.39M
48.55%973K
-11.61%2.26M
-29.21%4.45M
-76.36%553K
Net other financing activities
--0
--0
-500.00%-600K
-371.78%-769K
--0
--0
-2,776.00%-669K
46.24%-100K
13.76%-163K
--0
Cash from discontinued financing activities
Financing cash flow
-65.88%12.05M
-97.62%2.57M
-72.80%7.2M
804.96%170.48M
-4.70%527K
5,093.38%35.32M
15,807.65%108.17M
56.35%26.46M
-85.50%18.84M
-74.55%553K
Net cash flow
Beginning cash position
51.04%355.87M
35.09%172.79M
48.41%186.95M
1.68%125.97M
50.78%230.75M
95.59%235.61M
29.59%127.91M
1.68%125.97M
5.15%123.89M
26.72%153.04M
Current changes in cash
-4,524.55%-224.52M
69.99%183.08M
-829.09%-14.16M
2,711.57%60.98M
-61.34%-43.8M
-114.82%-4.86M
394.49%107.7M
107.70%1.94M
-65.00%2.17M
-975.43%-27.15M
Effect of exchange rate changes
----
----
----
--0
----
----
----
----
28.57%-90K
240.91%75K
End cash Position
-43.08%131.35M
51.04%355.87M
35.09%172.79M
48.41%186.95M
48.41%186.95M
50.78%230.75M
95.59%235.61M
29.59%127.91M
1.68%125.97M
1.68%125.97M
Free cash flow
-6.01%-28.64M
1,116.86%268.59M
19.46%-27.67M
34.96%-70.85M
153.43%16.94M
-6.51%-27.02M
-89.69%-26.41M
9.44%-34.36M
0.03%-108.93M
-16.84%-31.71M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.70%-27.86M1,123.79%268.62M20.14%-27.43M35.05%-70.24M153.61%16.96M-5.60%-26.61M-92.43%-26.24M8.81%-34.35M-0.25%-108.14M-17.43%-31.64M
Net income from continuing operations 2.62%-33.21M20.40%-30.62M714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M
Depreciation and amortization -21.77%647K8.65%892K-1.44%820K-1.69%3.31M-0.95%832K-3.05%827K-2.61%821K-0.12%832K21.41%3.37M2.56%840K
Other non cash items --------------194K--0--0--0--194K--------
Change In working capital -389.32%-2.63M7,144.00%291.06M-2,950.34%-243.33M-151.24%-19.51M-471.73%-16.46M232.94%908K-79.56%4.02M66.57%-7.98M-134.34%-7.77M-179.62%-2.88M
-Change in receivables 10.26%43K2,499,900.00%300M-707,321.95%-290.04M-335.50%-9.99M-12,295.12%-10M-98.52%39K-99.95%12K99.83%-41K563.61%4.24M-45.70%82K
-Change in prepaid assets -84.90%-1.16M-241.15%-2.01M-216.26%-915K-53.30%1.75M-94.88%171K-194.16%-629K192.83%1.42M-38.47%787K216.33%3.75M661.51%3.34M
-Change in payables and accrued expense 52.17%3.33M-168.55%-2.24M140.76%3.28M25.82%-8.53M-5.47%-5.94M166.05%2.19M231.21%3.26M-11,398.57%-8.05M-172.45%-11.5M-204.65%-5.63M
-Change in other current liabilities 76.05%-166K23.09%-523K-3.26%-696K-3.08%-2.74M-3.11%-696K-3.28%-693K-2.87%-680K-3.06%-674K-22.63%-2.66M0.30%-675K
-Change in other working capital ---4.68M---4.17M--45.05M--------------------87.57%-1.6M--0
Cash from discontinued investing activities
Operating cash flow -4.70%-27.86M1,123.79%268.62M20.14%-27.43M35.05%-70.24M153.61%16.96M-5.60%-26.61M-92.43%-26.24M8.81%-34.35M-0.25%-108.14M-17.43%-31.64M
Investing cash flow
Cash flow from continuing investing activities -1,439.27%-208.71M-442.05%-88.12M-38.21%6.07M-142.92%-39.26M-1,657.48%-61.29M-123.67%-13.56M-25.83%25.76M319.53%9.83M676.72%91.47M-85.88%3.94M
Net PPE purchase and sale -91.83%-775K84.09%-28K-2,320.00%-242K23.40%-609K72.86%-19K-149.38%-404K39.31%-176K96.34%-10K27.79%-795K64.29%-70K
Net investment purchase and sale -1,480.65%-207.94M-439.62%-88.09M-35.82%6.31M-141.89%-38.65M-1,629.79%-61.27M-122.90%-13.16M-25.94%25.94M334.02%9.84M725.13%92.26M-85.73%4.01M
Cash from discontinued investing activities
Investing cash flow -1,439.27%-208.71M-442.05%-88.12M-38.21%6.07M-142.92%-39.26M-1,657.48%-61.29M-123.67%-13.56M-25.83%25.76M319.53%9.83M676.72%91.47M-85.88%3.94M
Financing cash flow
Cash flow from continuing financing activities -65.88%12.05M-97.62%2.57M-72.80%7.2M804.96%170.48M-4.70%527K5,093.38%35.32M15,807.65%108.17M56.35%26.46M-85.50%18.84M-74.55%553K
Net common stock issuance --0--0--0807.72%132.1M--8K---78K--107.87M66.99%24.3M-88.25%14.55M--0
Proceeds from stock option exercised by employees -65.95%12.05M164.34%2.57M244.94%7.8M780.08%39.15M-6.15%519K5,089.59%35.39M48.55%973K-11.61%2.26M-29.21%4.45M-76.36%553K
Net other financing activities --0--0-500.00%-600K-371.78%-769K--0--0-2,776.00%-669K46.24%-100K13.76%-163K--0
Cash from discontinued financing activities
Financing cash flow -65.88%12.05M-97.62%2.57M-72.80%7.2M804.96%170.48M-4.70%527K5,093.38%35.32M15,807.65%108.17M56.35%26.46M-85.50%18.84M-74.55%553K
Net cash flow
Beginning cash position 51.04%355.87M35.09%172.79M48.41%186.95M1.68%125.97M50.78%230.75M95.59%235.61M29.59%127.91M1.68%125.97M5.15%123.89M26.72%153.04M
Current changes in cash -4,524.55%-224.52M69.99%183.08M-829.09%-14.16M2,711.57%60.98M-61.34%-43.8M-114.82%-4.86M394.49%107.7M107.70%1.94M-65.00%2.17M-975.43%-27.15M
Effect of exchange rate changes --------------0----------------28.57%-90K240.91%75K
End cash Position -43.08%131.35M51.04%355.87M35.09%172.79M48.41%186.95M48.41%186.95M50.78%230.75M95.59%235.61M29.59%127.91M1.68%125.97M1.68%125.97M
Free cash flow -6.01%-28.64M1,116.86%268.59M19.46%-27.67M34.96%-70.85M153.43%16.94M-6.51%-27.02M-89.69%-26.41M9.44%-34.36M0.03%-108.93M-16.84%-31.71M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List